nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.116	0.143	CbGbCtD
Quazepam—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.116	0.143	CbGbCtD
Quazepam—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0967	0.119	CbGbCtD
Quazepam—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0967	0.119	CbGbCtD
Quazepam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0742	0.0914	CbGbCtD
Quazepam—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0733	0.0903	CbGbCtD
Quazepam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0501	0.0618	CbGbCtD
Quazepam—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0488	0.0602	CbGbCtD
Quazepam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0478	0.0589	CbGbCtD
Quazepam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0426	0.0525	CbGbCtD
Quazepam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.025	0.0308	CbGbCtD
Quazepam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0236	0.0291	CbGbCtD
Quazepam—Thinking abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00393	0.0597	CcSEcCtD
Quazepam—Withdrawal syndrome—Prednisone—chronic obstructive pulmonary disease	0.00359	0.0546	CcSEcCtD
Quazepam—Mental disability—Salbutamol—chronic obstructive pulmonary disease	0.00312	0.0475	CcSEcCtD
Quazepam—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00235	0.0358	CcSEcCtD
Quazepam—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00231	0.0351	CcSEcCtD
Quazepam—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00209	0.0317	CcSEcCtD
Quazepam—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.0306	CcSEcCtD
Quazepam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00192	0.0292	CcSEcCtD
Quazepam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00177	0.0269	CcSEcCtD
Quazepam—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.0261	CcSEcCtD
Quazepam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00168	0.0255	CcSEcCtD
Quazepam—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00157	0.0239	CcSEcCtD
Quazepam—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.0225	CcSEcCtD
Quazepam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.0211	CcSEcCtD
Quazepam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00139	0.0211	CcSEcCtD
Quazepam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.0199	CcSEcCtD
Quazepam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0184	CcSEcCtD
Quazepam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0184	CcSEcCtD
Quazepam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.0182	CcSEcCtD
Quazepam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0012	0.0182	CcSEcCtD
Quazepam—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00119	0.00973	CbGpPWpGaD
Quazepam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00118	0.018	CcSEcCtD
Quazepam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00118	0.018	CcSEcCtD
Quazepam—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00118	0.00961	CbGpPWpGaD
Quazepam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00117	0.0178	CcSEcCtD
Quazepam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00117	0.0178	CcSEcCtD
Quazepam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.0178	CcSEcCtD
Quazepam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00115	0.0175	CcSEcCtD
Quazepam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.0173	CcSEcCtD
Quazepam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.0172	CcSEcCtD
Quazepam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.017	CcSEcCtD
Quazepam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.0169	CcSEcCtD
Quazepam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.0168	CcSEcCtD
Quazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.0011	0.009	CbGpPWpGaD
Quazepam—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00108	0.00885	CbGpPWpGaD
Quazepam—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00107	0.00877	CbGpPWpGaD
Quazepam—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00107	0.00875	CbGpPWpGaD
Quazepam—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00106	0.00867	CbGpPWpGaD
Quazepam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.016	CcSEcCtD
Quazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00105	0.00859	CbGpPWpGaD
Quazepam—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000977	0.00798	CbGpPWpGaD
Quazepam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000974	0.0148	CcSEcCtD
Quazepam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000974	0.0148	CcSEcCtD
Quazepam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000954	0.0145	CcSEcCtD
Quazepam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00092	0.014	CcSEcCtD
Quazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000899	0.00734	CbGpPWpGaD
Quazepam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000898	0.0137	CcSEcCtD
Quazepam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000898	0.0137	CcSEcCtD
Quazepam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000879	0.0134	CcSEcCtD
Quazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000866	0.00707	CbGpPWpGaD
Quazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000858	0.007	CbGpPWpGaD
Quazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000853	0.00697	CbGpPWpGaD
Quazepam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000851	0.0129	CcSEcCtD
Quazepam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000851	0.0129	CcSEcCtD
Quazepam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000848	0.0129	CcSEcCtD
Quazepam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000833	0.0127	CcSEcCtD
Quazepam—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000831	0.00679	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000829	0.00677	CbGpPWpGaD
Quazepam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.0122	CcSEcCtD
Quazepam—GABRR2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000791	0.00646	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000785	0.00641	CbGpPWpGaD
Quazepam—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000779	0.00636	CbGpPWpGaD
Quazepam—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000749	0.00611	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000749	0.00611	CbGpPWpGaD
Quazepam—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00071	0.0058	CbGpPWpGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000708	0.00578	CbGpPWpGaD
Quazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000706	0.00577	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000699	0.00571	CbGpPWpGaD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000696	0.00568	CbGpPWpGaD
Quazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000696	0.00568	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000684	0.00558	CbGpPWpGaD
Quazepam—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000683	0.00557	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000679	0.00555	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000676	0.00552	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000667	0.00545	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000667	0.00545	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000651	0.00532	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000645	0.00526	CbGpPWpGaD
Quazepam—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000644	0.00526	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000642	0.00524	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000635	0.00519	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000616	0.00503	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000607	0.00496	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000606	0.00495	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000583	0.00476	CbGpPWpGaD
Quazepam—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000578	0.00472	CbGpPWpGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000578	0.00472	CbGpPWpGaD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000567	0.00463	CbGpPWpGaD
Quazepam—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000566	0.00462	CbGpPWpGaD
Quazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00056	0.00457	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000557	0.00455	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000554	0.00452	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000549	0.00449	CbGpPWpGaD
Quazepam—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000544	0.00444	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000544	0.00444	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000541	0.00442	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000533	0.00435	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000531	0.00434	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000523	0.00427	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000523	0.00427	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000518	0.00423	CbGpPWpGaD
Quazepam—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000516	0.00421	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000514	0.0042	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000511	0.00417	CbGpPWpGaD
Quazepam—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000509	0.00416	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000504	0.00412	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000501	0.00409	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000499	0.00407	CbGpPWpGaD
Quazepam—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000496	0.00405	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000495	0.00404	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000494	0.00403	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000492	0.00401	CbGpPWpGaD
Quazepam—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000488	0.00398	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000486	0.00397	CbGpPWpGaD
Quazepam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000486	0.0074	CcSEcCtD
Quazepam—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000483	0.00395	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000475	0.00388	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000475	0.00387	CbGpPWpGaD
Quazepam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00047	0.00716	CcSEcCtD
Quazepam—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000468	0.00382	CbGpPWpGaD
Quazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000464	0.00379	CbGpPWpGaD
Quazepam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000461	0.00701	CcSEcCtD
Quazepam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000461	0.00701	CcSEcCtD
Quazepam—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00045	0.00368	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000449	0.00367	CbGpPWpGaD
Quazepam—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000448	0.00366	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000441	0.0036	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000438	0.00358	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000434	0.00354	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000434	0.00354	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000431	0.00352	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000426	0.00348	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000423	0.00345	CbGpPWpGaD
Quazepam—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00042	0.00343	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000419	0.00342	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000416	0.0034	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000415	0.00339	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000409	0.00334	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000408	0.00333	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000407	0.00332	CbGpPWpGaD
Quazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000407	0.00332	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000401	0.00327	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000401	0.00327	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000394	0.00322	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000391	0.00319	CbGpPWpGaD
Quazepam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00039	0.00319	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000384	0.00314	CbGpPWpGaD
Quazepam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000383	0.00583	CcSEcCtD
Quazepam—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000374	0.00305	CbGpPWpGaD
Quazepam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00037	0.00302	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00037	0.00302	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000359	0.00293	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000357	0.00292	CbGpPWpGaD
Quazepam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000353	0.00538	CcSEcCtD
Quazepam—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000341	0.00278	CbGpPWpGaD
Quazepam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00034	0.00278	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000336	0.00274	CbGpPWpGaD
Quazepam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00509	CcSEcCtD
Quazepam—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000333	0.00272	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000331	0.0027	CbGpPWpGaD
Quazepam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000327	0.00267	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000327	0.00267	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000324	0.00264	CbGpPWpGaD
Quazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.00264	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000321	0.00262	CbGpPWpGaD
Quazepam—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000319	0.00261	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000319	0.0026	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000313	0.00256	CbGpPWpGaD
Quazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000306	0.0025	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000302	0.00246	CbGpPWpGaD
Quazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000295	0.00241	CbGpPWpGaD
Quazepam—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000291	0.00238	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000274	0.00224	CbGpPWpGaD
Quazepam—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000272	0.00222	CbGpPWpGaD
Quazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000262	0.00214	CbGpPWpGaD
Quazepam—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.00202	CbGpPWpGaD
Quazepam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00024	0.00196	CbGpPWpGaD
Quazepam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000239	0.00195	CbGpPWpGaD
Quazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.00192	CbGpPWpGaD
Quazepam—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000232	0.00189	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000225	0.00183	CbGpPWpGaD
Quazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000214	0.00175	CbGpPWpGaD
Quazepam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000211	0.00173	CbGpPWpGaD
Quazepam—Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.367	CrCbGaD
Quazepam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000199	0.00162	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000199	0.00162	CbGpPWpGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000194	0.00159	CbGpPWpGaD
Quazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000192	0.00157	CbGpPWpGaD
Quazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00019	0.00155	CbGpPWpGaD
Quazepam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00143	CbGpPWpGaD
Quazepam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000174	0.00142	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000168	0.00137	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000166	0.00135	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.00129	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000154	0.00126	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000153	0.00125	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000151	0.00123	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000147	0.0012	CbGpPWpGaD
Quazepam—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000147	0.264	CrCbGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.00115	CbGpPWpGaD
Quazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.00114	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.00114	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.00112	CbGpPWpGaD
Quazepam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.234	CrCbGaD
Quazepam—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00104	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00102	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000123	0.001	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000121	0.000987	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000119	0.000973	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000118	0.000962	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000118	0.000961	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000116	0.000948	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000115	0.000935	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.000935	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000107	0.000877	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000107	0.000871	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000106	0.000864	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000105	0.000859	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000104	0.000853	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.000826	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000101	0.000823	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.98e-05	0.000815	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.97e-05	0.000814	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.96e-05	0.000813	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.89e-05	0.000807	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.73e-05	0.000794	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.71e-05	0.000793	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.6e-05	0.000784	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.54e-05	0.000779	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.48e-05	0.000774	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.31e-05	0.00076	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.24e-05	0.000755	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.22e-05	0.000753	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.1e-05	0.000743	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.82e-05	0.00072	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	8.54e-05	0.000698	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.37e-05	0.000684	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.26e-05	0.000674	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	8.14e-05	0.000664	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.14e-05	0.000664	CbGpPWpGaD
Quazepam—Diazepam—ALB—chronic obstructive pulmonary disease	7.51e-05	0.135	CrCbGaD
Quazepam—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	7.42e-05	0.000606	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.26e-05	0.000593	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.15e-05	0.000584	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.98e-05	0.00057	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.9e-05	0.000563	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.89e-05	0.000562	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.42e-05	0.000524	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.33e-05	0.000517	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.08e-05	0.000497	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6e-05	0.00049	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.94e-05	0.000485	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.83e-05	0.000476	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.8e-05	0.000474	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.73e-05	0.000468	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.69e-05	0.000465	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.59e-05	0.000456	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.39e-05	0.00044	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.35e-05	0.000437	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.29e-05	0.000432	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	5.24e-05	0.000428	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.92e-05	0.000401	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.89e-05	0.0004	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.89e-05	0.000399	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.88e-05	0.000398	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.87e-05	0.000398	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.78e-05	0.00039	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.45e-05	0.000363	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.88e-05	0.000317	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.54e-05	0.000289	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.24e-05	0.000265	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.15e-05	0.000257	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.93e-05	0.000239	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.86e-05	0.000234	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.83e-05	0.000231	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.64e-05	0.000216	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.61e-05	0.000213	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.58e-05	0.000211	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.58e-05	0.000211	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.41e-05	0.000197	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.38e-05	0.000194	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.36e-05	0.000192	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.17e-05	0.000177	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.99e-05	0.000162	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.96e-05	0.00016	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.82e-05	0.000149	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.81e-05	0.000148	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.79e-05	0.000146	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000141	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000141	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.000139	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.66e-05	0.000136	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.58e-05	0.000129	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000127	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000117	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	9.75e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	9.62e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-05	9.6e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-05	9.18e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	8.96e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.07e-05	8.75e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	8.49e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	8.37e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.07e-06	5.77e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.76e-06	5.52e-05	CbGpPWpGaD
